Financiën Abbott Laboratories

Aandelen

ABT

US0028241000

Medische apparatuur, benodigdheden & distributie

Geschatte realtime Cboe BZX Andere beurzen 16:52:55 10-02-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
112,05 ^USD	+0,88%		+2,68%	-10,65%

06/02	Abbott Laboratories: Nieuwe Gegevens Ondersteunen Veiligheid en Effectiviteit van Ablatiekatheters	MT
06/02	Abbott Laboratories presenteert nieuwe klinische gegevens uit twee late-breaking presentaties op het AF Symposium in Boston	CI

Voorlopige winst- en verliesrekening: Abbott Laboratories

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Omzet ¹	34.608	43.075	43.653	40.109	41.950	44.328	47.915	51.512
Variatie	-	24,47%	1,34%	-8,12%	4,59%	5,67%	8,09%	7,51%
EBITDA ¹	9.204	12.815	12.485	10.188	10.635	11.873	12.890	14.123
Variatie	-	39,23%	-2,58%	-18,4%	4,39%	11,65%	8,56%	9,56%
Bedrijfsresultaat (EBIT) ¹	8.009	11.324	11.231	8.911	9.295	10.301	11.422	12.660
Variatie	-	41,39%	-0,82%	-20,66%	4,31%	10,82%	10,88%	10,84%
Betaalde rente ¹	-500	-490	-375	-252	-215	-185	-187,9	-182,5
Resultaat voor belastingen (EBT) ¹	4.968	8.211	8.306	6.664	7.013	8.466	9.497	10.812
Variatie	-	65,28%	1,16%	-19,77%	5,24%	20,72%	12,18%	13,84%
Nettowinst (verlies) ¹	4.471	7.071	6.933	5.723	13.402	6.524	7.919	8.849
Variatie	-	58,15%	-1,95%	-17,45%	134,18%	-51,32%	21,39%	11,74%
Datum van publicatie	27/01/21	26/01/22	25/01/23	24/01/24	22/01/25	22/01/26	-	-

¹USD in Miljoen

Geschatte gegevens

Fiscaal tijdperk: december	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3
Omzet ¹	10.701	10.456	10.223	10.928	11.468	11.895	11.257	10.410	10.091	9.747	9.978	10.143	10.241	9.964	10.377	10.635	10.974	10.358	11.142	11.369	11.459	10.994	11.895	12.298	12.715	11.973	12.892	13.246
Variatie	-	-2,29%	-2,23%	6,9%	4,94%	3,72%	-5,36%	-7,52%	-3,06%	-3,41%	2,37%	1,65%	0,97%	-2,7%	4,14%	2,49%	3,19%	-5,61%	7,57%	2,04%	0,79%	-4,06%	8,2%	3,39%	3,38%	-5,83%	7,67%	2,75%
EBITDA ¹	3.464	3.265	2.918	3.369	3.263	4.247	3.300	2.812	2.442	2.372	2.467	2.606	2.743	2.292	2.607	2.730	3.006	2.514	2.908	2.981	3.423	2.679	3.198	3.400	3.774	3.233	3.633	3.789
Variatie	-	-5,74%	-10,63%	15,46%	-3,15%	30,16%	-22,3%	-14,79%	-13,16%	-2,87%	4,01%	5,63%	5,26%	-16,44%	13,74%	4,72%	10,11%	-16,37%	15,67%	2,51%	0%	-21,75%	19,4%	6,31%	10,98%	-14,31%	12,35%	4,31%
Bedrijfsresultaat (EBIT) ¹	3.106	2.840	2.548	3.042	2.894	3.620	2.985	2.495	2.131	2.057	2.165	2.278	2.411	1.959	2.273	2.399	2.664	2.178	2.551	2.610	2.962	2.270	2.780	2.973	3.399	2.729	3.117	3.287
Variatie	-	-8,56%	-10,28%	19,39%	-4,87%	25,09%	-17,54%	-16,42%	-14,59%	-3,47%	5,25%	5,22%	5,84%	-18,75%	16,03%	5,54%	11,05%	-18,24%	17,13%	2,31%	13,49%	-23,37%	22,47%	6,94%	14,34%	-19,73%	14,26%	5,44%
Charge d'intérêts ¹	-127	-124	-123	-123	-120	-117	-106	-86	-66	-52	-61	-69	-70	-61	-58	-51	-45	-49	-50	-44	-42	-47,92	-47	-47,5	-46,67	-45	-45	-44
Resultaat voor belastingen (EBT) ¹	-	2.043	-	-	-	-	-	-	-	1.562	1.636	1.671	1.795	1.436	1.607	1.940	2.030	1.778	2.150	2.180	2.358	1.858	2.304	2.472	2.781	2.198	2.600	2.749
Variatie	-	-	-	-	-	-	-	-	-	-	4,74%	2,14%	7,42%	-20%	11,91%	20,72%	4,64%	-12,41%	20,92%	1,4%	8,17%	-21,19%	24%	7,26%	12,53%	-20,99%	18,31%	5,73%
Nettowinst (verlies) ¹	2.158	1.793	1.189	2.100	1.989	2.447	2.018	1.435	1.033	1.318	1.375	1.436	1.594	1.225	1.302	1.646	9.229	1.325	1.779	1.644	1.776	1.515	1.919	2.062	2.385	1.821	2.164	2.317
Variatie	-	-16,91%	-33,69%	76,62%	-5,29%	23,03%	-17,53%	-28,89%	-28,01%	27,59%	4,32%	4,44%	11%	-23,15%	6,29%	26,42%	460,69%	-85,64%	34,26%	-7,59%	8,03%	-14,68%	26,62%	7,44%	15,69%	-23,65%	18,82%	7,09%
Datum van publicatie	27/01/21	20/04/21	22/07/21	20/10/21	26/01/22	20/04/22	20/07/22	19/10/22	25/01/23	19/04/23	20/07/23	18/10/23	24/01/24	17/04/24	18/07/24	16/10/24	22/01/25	16/04/25	17/07/25	15/10/25	22/01/26	-	-	-	-	-	-	-

¹USD in Miljoen

Geschatte gegevens

Balansprognose: Abbott Laboratories

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Nettoschuld ¹	11.909	7.801	6.891	7.783	6.509	3.475	596	-2.472
Variatie	-	-34,49%	-11,67%	12,94%	-16,37%	-46,61%	-82,85%	-514,77%
Datum van publicatie	27/01/21	26/01/22	25/01/23	24/01/24	22/01/25	22/01/26	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte kasstroom: Abbott Laboratories

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	2.177	1.885	1.777	2.202	2.207	2.355	2.573	2.590
Variatie	-	-13,41%	-5,73%	23,92%	0,23%	6,69%	9,28%	0,64%
Vrije kasstroom (FCF) ¹	5.724	8.648	7.804	5.059	6.351	7.956	8.928	8.836
Variatie	-	51,08%	-9,76%	-35,17%	25,54%	25,27%	12,22%	-1,03%
Datum van publicatie	27/01/21	26/01/22	25/01/23	24/01/24	22/01/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte financiële ratio's: Abbott Laboratories

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Winstgevendheid
EBITDA-marge (%)	26,6%	29,75%	28,6%	25,4%	25,35%	26,58%	26,9%	27,42%
EBIT-marge (%)	23,14%	26,29%	25,73%	22,22%	22,16%	23,24%	23,84%	24,58%
EBT-marge (%)	14,36%	19,06%	19,03%	16,61%	16,72%	19,1%	19,82%	20,99%
Nettomarge (%)	12,92%	16,42%	15,88%	14,27%	31,95%	14,72%	16,53%	17,18%
FCF-marge (%)	16,54%	20,08%	17,88%	12,61%	15,14%	17,81%	18,63%	17,15%
Vrije kasstroom/nettoresultaat (%)	128,03%	122,3%	112,56%	88,4%	47,39%	114,92%	112,74%	99,85%
Winstgevendheid
ROA	9,33%	9,57%	12,65%	10,57%	10,61%	9,13%	9,9%	10,74%
ROE	20,52%	27,32%	26,12%	20,73%	19,01%	17,96%	18,8%	19,8%
Financiële gezondheid
Hefboom (schuld/ebitda)	1,29x	0,61x	0,55x	0,76x	0,61x	0,29x	0,05x	-
Schuld/vrije kasstroom	2,08x	0,9x	0,88x	1,54x	1,02x	0,44x	0,07x	-
Kapitaalintensiteit
Kapitaaluitgaven/omzet (%)	6,29%	4,38%	4,07%	5,49%	5,26%	5,27%	5,37%	5,03%
CAPEX / EBITDA (%)	23,65%	14,71%	14,23%	21,61%	20,75%	19,83%	19,96%	18,34%
CAPEX / FCF (%)	38,03%	21,8%	22,77%	43,53%	34,75%	29,59%	28,82%	29,31%
Bestanddelen per aandeel
Kasstroom per aandeel ¹	4,424	5,888	5,431	4,152	4,896	6,474	6,669	7,335
Variatie	-	33,1%	-7,76%	-23,56%	17,93%	32,24%	3%	10%
Dividend per aandeel ¹	1,53	1,82	1,92	2,08	2,24	2,377	2,522	2,663
Variatie	-	18,95%	5,49%	8,33%	7,69%	6,11%	6,11%	5,6%
Nettoactief per aandeel ¹	18,5	20,3	21,11	22,26	27,52	28,61	29,48	30,43
Variatie	-	9,7%	4,02%	5,45%	23,64%	3,96%	3,04%	3,22%
WPA ¹	2,49	3,94	3,91	3,26	7,64	3,72	4,515	5,065
Variatie	-	58,23%	-0,76%	-16,62%	134,36%	-51,31%	13,53%	12,18%
Aantal aandelen (in duizend)	1.713.401	1.714.968	1.743.574	1.736.059	1.734.455	1.738.834	1.738.834	1.738.834
Datum van publicatie	27/01/21	26/01/22	25/01/23	24/01/24	22/01/25	22/01/26	-	-